Global Nutrigenomics Market By Product Type: (Reagents & Kits, Services) By Application: (Obesity Management, Cancers, Heart Diseases) By End-Use: (Hospitals, Research Institutes) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: Feb 2022
- Report ID: 84292
- Number of Pages: 304
- Format:
- keyboard_arrow_up
Nutrigenomics Market Overview:
The global Nutrigenomics Market is projected to reach a valuation of USD 2486.08 Mn by 2032 at a CAGR of 16.48%, from USD 540.76 Mn in 2022.
The interface between a healthy environment and cellular/genetic processes is called nutritional genomics or nutrigenomics. It helps to study the effects of diet on an individual’s genes and health. Nutrigenomics seeks to provide a genetic understanding of nutrition affecting the balance between health and disease. Nutritional genetics is the combination of nutrigenomics and nutrigenetics.
It also determines individual nutritional requirements based on the genetic makeup of a person (personalized diet). It also helps to understand the etiologic aspects of chronic diseases such as cancer, type-2 diabetes, obesity, and cardiovascular diseases. On the other hand, Nutrigenetics identifies how the genetic makeup of a particular individual coordinates their response to various dietary nutrients. It also reveals why and how individuals respond differently to the same nutrient.
Detailed Segmentation:
The nutrigenomics market is segmented on the basis of – type, application, and region.
By Product Type –
- Reagents & Kits
- Services
By Application-
- Obesity Management
- Cancers
- Heart Diseases
- Diabetes
By End-Use –
- Hospitals
- Research Institutes
- Homecare Settings
- Other End-Uses
Market segment by Region-
- North America
- Europe
- APAC
- South America
- MEA
Market Dynamics:
New tools now available in a post-genomic era, opens up possibilities for nutritionists to screen the genetic background, monitor the transcriptome, proteome, and metabolome, and ultimately develop dietary strategies which are targeted to supply the optimum nutrition for single individuals. These tools are the focus of the emerging field of nutrigenomics.
The future aim of nutrigenomics is to understand how the whole body responds to natural foods using an integrated approach termed ‘systems biology.’ The most important advantage of nutrigenomics is that the studies can examine people (i.e., populations, sub-populations – based on genes or disease and individuals), food, life stage, and lifestyle without preconceived ideas. Nutrigenomic approaches will enhance researchers’ abilities to maintain animal health, optimize animal performance, as well as to improve milk and meat quality.
Despite its recognized potential future benefits, nutrigenomics nevertheless raises several ethical issues and risks that are similar to ‘genethics’ or ethics in genetics: a predisposition to developing a disease might trigger anxiety and stress in an individual, the privacy of the patient might be jeopardized, potential discrimination against affected individuals by employers, health insurance companies, family, and other unrecognized risks.
Key Players:
- 23andMe Inc.
- GX Sciences Inc.
- DNAfit
- Vitagene
- Mapmygenome
- Nutrigenomix
- gini Health Pvt. Ltd.
- Xcode Life
- geneOmbio Technologies Pvt. Ltd.
- Other Key Players
Key Developments:
In July 2017, DNAfit launched five new DNA-based products developed in collaboration with Helix, which launched the first online marketplace for DNA-powered products.
In June 2018, 23andMe Inc. collaborated with GlaxoSmithKline to focus on research & development of innovative medicine and potential cures using human genetics as the basis of discovery.
In February 2018, 23andME launched “The Global Genetic Project” to enrich the understanding of human genetic diversity and power insights into health conditions that may impact populations that are underrepresented in genetic research.
In June 2017, DNAfit and Vita Mojo teamed up to create the world’s most personalized restaurant menu, exclusively designed for each customer’s DNA.
For the Nutrigenomics Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
- 23andMe Inc.
- GX Sciences Inc.
- DNAfit
- Vitagene
- Mapmygenome
- Nutrigenomix
- gini Health Pvt. Ltd.
- Xcode Life
- geneOmbio Technologies Pvt. Ltd.
- Other Key Players
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |